Zobrazeno 1 - 7
of 7
pro vyhledávání: '"T K, Makris"'
Autor:
D P, Papadopoulos, I, Moyssakis, T K, Makris, M, Poulakou, G, Stavroulakis, D, Perrea, V E, Votteas
Publikováno v:
European cytokine network. 16(2)
Matrix metalloproteinases (MMP) degrade myocardial fibrillar collagen in acute myocardial infarction (MI) patients. Their activity is tightly controlled in normal myocardium by a family of closely related tissue inhibitors known as TIMP. An imbalance
Autor:
T K, Makris, G, Stavroulakis, D P, Papadopoulos, P, Krespi, A, Hatzizacharias, A, Zilidis, C, Tsoukala, V E, Votteas
Publikováno v:
Drugs under experimental and clinical research. 30(3)
Essential hypertension is often accompanied by abnormalities of the coagulation/fibrinolytic system predisposing to a procoagulant state. The aim of the present study was to examine the comparative efficacy of the angiotensin II type 1 receptor antag
Autor:
D P, Papadopoulos, E V, Economou, T K, Makris, K J, Kapetanios, I, Moyssakis, V E, Votteas, P K, Toutouzas
Publikováno v:
Drugs under experimental and clinical research. 30(2)
Matrix metalloproteinases and their tissue inhibitors are key enzymes degrading myocardial collagen in acute myocardial infarction (AMI). The aim of the present study was to determine whether angiotensin-converting enzyme inhibitors (ACEI) influence
Publikováno v:
Thrombosis and haemostasis. 84(5)
Autor:
G A, Stavroulakis, T K, Makris, P G, Krespi, A N, Hatzizacharias, A E, Gialeraki, G, Anastasiadis, P, Triposkiadis, M, Kyriakidis
Publikováno v:
Cardiovascular drugs and therapy. 14(4)
Insertion (I)/deletion (D) polymorphism of the ACE gene has been reported to be involved in various cardiovascular diseases. We investigated prospectively whether the response to the ACE inhibitor fosinopril varied according to the ACE genotype in pr
Autor:
T K, Makris, G, Stavroulakis, A N, Hatzizacharias, P G, Krespi, C G, Tsoukala, F K, Triposkiadis, T, Mandalaki, M, Kyriakidis
Publikováno v:
Thrombosis and haemostasis. 81(4)
Autor:
P G, Krespi, T K, Makris, A N, Hatzizacharias, P, Triposkiadis, C, Tsoukala, D, Kyriaki, V, Votteas, M, Kyriakidis
Publikováno v:
Cardiovascular drugs and therapy. 12(5)
Increased sympathetic activity seems to play an important role in the pathogenesis and development of complications of atherosclerotic origin in patients with essential hypertension (EH). The aim of this study was to evaluate the effect of a new anti